Physician profile
Angelo Ostuni
NPI 1093976292
$3,668.85
in general payments reported to CMS, 2019-2025
9 companies · $211 in 2025
The $211 reported for 2025 was more than what a typical Oral and Maxillofacial Surgery provider received nationally (typical 2025 total: $150).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $766 · 2020: $198 · 2021: $291 · 2022: $1,568 · 2023: $531 · 2024: $105 · 2025: $211.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $697 · Education: $150.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $696.89 |
| Education | $150.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Straumann USA LLC | $2,097.10 | 2019-2025 | |
| Geistlich Pharma, North America, INC. | $558.36 | 2019-2025 | Biomaterials, Geistlich Bio-Gide |
| Nobel Biocare USA | $328.38 | 2019-2023 | Nobelactive |
| Biohorizons Implant Systems INC. | $270.54 | 2020-2025 | Biohorizons, Biohorizons Dental Instruments |
| Southern Implants North America INC | $132.19 | 2019 | |
| Meisinger USA, LLC | $118.95 | 2020 | |
| 3d Systems | $100.58 | 2022 | |
| Medical Device Business Services, INC. | $43.52 | 2021 | |
| Vertex Pharmaceuticals Incorporated | $19.23 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Angelo Ostuni listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.